712 related articles for article (PubMed ID: 22480743)
1. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC
Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
[TBL] [Abstract][Full Text] [Related]
2. [Complications of intravitreal injections--own experience].
Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
[TBL] [Abstract][Full Text] [Related]
3. Bilateral simultaneous intravitreal injections in the office setting.
Bakri SJ; Risco M; Edwards AO; Pulido JS
Am J Ophthalmol; 2009 Jul; 148(1):66-9.e1. PubMed ID: 19403114
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
[TBL] [Abstract][Full Text] [Related]
5. Acute endophthalmitis after intravitreal injection and preventive effect of preoperative topical antibiotics.
Park Y; Kim KS; Park YH
J Ocul Pharmacol Ther; 2013 Dec; 29(10):900-5. PubMed ID: 24067061
[TBL] [Abstract][Full Text] [Related]
6. An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone.
Sheyman AT; Cohen BZ; Friedman AH; Ackert JM
JAMA Ophthalmol; 2013 Jul; 131(7):864-9. PubMed ID: 23640384
[TBL] [Abstract][Full Text] [Related]
7. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
Jonas JB; Kreissig I; Spandau UH; Harder B
Am J Ophthalmol; 2006 Mar; 141(3):579-80. PubMed ID: 16490517
[TBL] [Abstract][Full Text] [Related]
8. ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics.
Li AL; Wykoff CC; Wang R; Chen E; Benz MS; Fish RH; Wong TP; Major JC; Brown DM; Schefler AC; Kim RY; OʼMalley RE
Retina; 2016 Jul; 36(7):1349-56. PubMed ID: 26655622
[TBL] [Abstract][Full Text] [Related]
9. Eliminating antibiotic prophylaxis for intravitreal injections: a consecutive series of 18,839 injections by a single surgeon.
Bhavsar AR; Sandler DR
Retina; 2015 Apr; 35(4):783-8. PubMed ID: 25526099
[TBL] [Abstract][Full Text] [Related]
10. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.
Bhavsar AR; Googe JM; Stockdale CR; Bressler NM; Brucker AJ; Elman MJ; Glassman AR;
Arch Ophthalmol; 2009 Dec; 127(12):1581-3. PubMed ID: 20008710
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
12. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
Lorenzo Carrero J; Pérez Flores I; González Barcia M
Am J Ophthalmol; 2006 Sep; 142(3):529; author reply 529-30. PubMed ID: 16935616
[No Abstract] [Full Text] [Related]
13. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
Storey P; Dollin M; Pitcher J; Reddy S; Vojtko J; Vander J; Hsu J; Garg SJ;
Ophthalmology; 2014 Jan; 121(1):283-289. PubMed ID: 24144453
[TBL] [Abstract][Full Text] [Related]
14. Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting.
Tabandeh H; Boscia F; Sborgia A; Ciracì L; Dayani P; Mariotti C; Furino C; Flynn HW
Retina; 2014 Jan; 34(1):18-23. PubMed ID: 24362413
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
Bhatt SS; Stepien KE; Joshi K
Retina; 2011 Nov; 31(10):2032-6. PubMed ID: 21659941
[TBL] [Abstract][Full Text] [Related]
16. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
17. [Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide].
Le Moigne O; Duncombe A; Portmann A; Muraine M; Genevois O
J Fr Ophtalmol; 2012 Nov; 35(9):700-4. PubMed ID: 22925843
[TBL] [Abstract][Full Text] [Related]
18. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics.
Hsu J; Gerstenblith AT; Garg SJ; Vander JF
Am J Ophthalmol; 2014 Mar; 157(3):514-8.e1. PubMed ID: 24332373
[TBL] [Abstract][Full Text] [Related]
19. Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis.
Taban M; Singh RP; Chung JY; Lowder CY; Perez VL; Kaiser PK
Am J Ophthalmol; 2007 Jul; 144(1):50-54. PubMed ID: 17601427
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
Englander M; Chen TC; Paschalis EI; Miller JW; Kim IK
Br J Ophthalmol; 2013 Apr; 97(4):460-5. PubMed ID: 23390167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
